(Q48502124)

12 February 2018

title

Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA. (English)

1 reference

12 February 2018

author name string

D'Souza U

series ordinal

1

1 reference

12 February 2018

McGuffin P

series ordinal

2

1 reference

12 February 2018

Buckland PR

series ordinal

3

1 reference

12 February 2018

publication date

1 November 1997

1 reference

12 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

12 February 2018

volume

36

1 reference

12 February 2018

issue

11-12

1 reference

12 February 2018

page(s)

1689-1696

1 reference

12 February 2018

Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2C receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Stereospecific effect of flupenthixol on neuroreceptor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

The effects of haloperidol on dopamine receptor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Haloperidol treatment increases D2 dopamine receptor protein independently of RNA levels in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Dopamine D3 receptor mRNA and binding sites in human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Visualization of D1 dopamine receptors on living nucleus accumbens neurons and their colocalization with D2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Up-regulation of D3 dopamine receptor mRNA by neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

Continuous infusion of clozapine increases mu and delta opioid receptors and proenkephalin mRNA in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900163-9

10.1016/S0028-3908(97)00163-9

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9517440

1 reference

12 February 2018